Medication info

Mineblu 5 Weeks

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCopper Sulfate›1.57mg / 1mLManganese Sulfate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
A colorless transparent vial injection containing a colorless, odorless, or slightly blue transparent liquid.
Packaging
10mL x 10 vials
Approval status
Active

MFDS item code 201700101 · Notified 2017.01.04

Summary

Main use
Prevention of trace element deficiencies (including zinc, copper, and manganese) during intravenous nutritional supplementation
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment. Patients receiving parenteral nutrition who are metabolically stable: Zinc 2.5∼4㎎ per day Patients receiving parenteral nutrition who are metabolically stable: Copper 0.5∼1.5㎎ per day Patients receiving parenteral nutrition who are metabolically stable: Manganese 0.15∼0.8㎎ per day Patients receiving parenteral nutrition who are metabolically stable: Chromium 10∼15㎍ per day Patients receiving parenteral nutrition who are metabolically stable: Selenium 20∼40㎍ per day Patients with small intestinal fluid losses who are metabolically stable: Additional 12.2㎎/L (volume of small intestinal fluid lost) or 17.1㎎/㎏ (amount of stool) Patients in an acute catabolic state: 4.5∼6㎎ per day Patients with small intestinal fluid losses who are metabolically stable: 20㎍ per day Deficiency due to long-term parenteral nutrition: 100㎍ per day may be used for 24∼31 days.
Child administration
Children 5 years of age and younger: Zinc 100㎍/㎏ body weight per day Children 5 years of age and younger: Copper 20㎍/㎏ body weight per day Children 5 years of age and younger: Manganese 2∼10㎍/㎏ body weight per day Children 5 years of age and younger: Chromium 0.14∼0.20㎍/㎏ body weight per day Children 5 years of age and younger: Selenium 3㎍/㎏ body weight per day

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Prevention of trace element deficiencies (including zinc, copper, and manganese) during intravenous nutritional supplementation

View approved original text

By adequately supplying trace elements such as zinc, copper, manganese, selenium, and chromium during intravenous nutrition, this medication maintains the patient's nutritional status in balance and prevents complications associated with deficiencies in essential minerals. These trace elements play crucial roles in bodily metabolism, immune function, and cell regeneration, aiding recovery during the treatment process. Therefore, the provision of trace elements during intravenous nutritional therapy is essential for the overall improvement of the patient's health.

How it is given

Adult administration

Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment. Patients receiving parenteral nutrition who are metabolically stable: Zinc 2.5∼4㎎ per day Patients receiving parenteral nutrition who are metabolically stable: Copper 0.5∼1.5㎎ per day Patients receiving parenteral nutrition who are metabolically stable: Manganese 0.15∼0.8㎎ per day Patients receiving parenteral nutrition who are metabolically stable: Chromium 10∼15㎍ per day Patients receiving parenteral nutrition who are metabolically stable: Selenium 20∼40㎍ per day Patients with small intestinal fluid losses who are metabolically stable: Additional 12.2㎎/L (volume of small intestinal fluid lost) or 17.1㎎/㎏ (amount of stool) Patients in an acute catabolic state: 4.5∼6㎎ per day Patients with small intestinal fluid losses who are metabolically stable: 20㎍ per day Deficiency due to long-term parenteral nutrition: 100㎍ per day may be used for 24∼31 days.

Child administration

Children 5 years of age and younger: Zinc 100㎍/㎏ body weight per day Children 5 years of age and younger: Copper 20㎍/㎏ body weight per day Children 5 years of age and younger: Manganese 2∼10㎍/㎏ body weight per day Children 5 years of age and younger: Chromium 0.14∼0.20㎍/㎏ body weight per day Children 5 years of age and younger: Selenium 3㎍/㎏ body weight per day

Precautions

This medication should not be used in premature infants or newborns due to the risk of severe respiratory problems caused by the ingredient benzyl alcohol. If this medication is injected directly into the vein without dilution, phlebitis may occur, so it must be used diluted. Additionally, since this medication is a hypotonic solution, it should only be used in mixed infusions. If toxic symptoms appear during the use of this medication, administration must be stopped immediately. Special caution is required because aluminum can accumulate and show toxicity in patients with impaired kidney function or in premature infants. The trace elements contained in this medication, such as zinc, copper, manganese, chromium, and selenium, are generally rare in toxicity due to their small doses, but dosage adjustment and monitoring of blood concentration are essential. Patients with renal failure may accumulate zinc, and patients with biliary obstruction are at risk of accumulating copper and manganese. Furthermore, chromium can affect blood sugar control in diabetes patients, so it is crucial to verify the diabetes treatment. The safety of this medication in pregnant women has not been established; therefore, it should be used only when the therapeutic benefits outweigh the risks for females who are pregnant or may become pregnant. In case of overdose, trace elements such as zinc, copper, chromium, and selenium can cause toxicity, so strict adherence to the prescribed dosage is necessary. Appropriate treatment is required depending on the symptoms in case of overdose. This medication must be used under a doctor's prescription, and when added to parenteral nutrition solutions, it is safe to maintain sterile conditions and work in a laminar flow environment. During storage, it should be kept in a sealed container to prevent contact with air, and the temperature should be maintained in a cool place between 15 degrees and 30 degrees Celsius. This will help maintain the medication's effects and ensure safe use.

Side effects

Shortness of breath, sweating, decreased consciousness, blurred vision, tachycardia, hypothermia, hyperamylasemia, hypotension, pulmonary edema, diarrhea, vomiting, jaundice, decreased urine output, exhaustion, behavioral changes, progressive wasting syndrome, photophobia, peripheral edema, nausea, ulcers, gastrointestinal disturbances, kidney impairment, liver dysfunction, seizures, coma, hair loss, nail weakness, dermatitis, dental damage, irritability, depression, metallic taste, garlic odor during sweating and breathing, acute peripheral vascular collapse, vascular congestion, pulmonary hemorrhage, congestion, and edema, gastric mucosal discoloration, coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid contact with air, in a cool place between 15 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

A colorless transparent vial injection containing a colorless, odorless, or slightly blue transparent liquid.

Package unit

10mL x 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.